Trial Profile
Open Label, Single Center, Nonrandomized Study Comparing Efficacy of To Be Marketed Cholic Acid With That of the Currently Used Formulation of Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2023
Price :
$35
*
At a glance
- Drugs Cholic acid (Primary)
- Indications Inborn genetic disorders
- Focus Registrational; Therapeutic Use
- Sponsors Asklepion Pharmaceuticals; Mirum Pharmaceuticals; Retrophin
- 03 Feb 2015 New trial record